Glucotrack effectiates 1-for-15 reverse split to meet Nasdaq bid price requirements.

Glucotrack will reduce its outstanding shares to approximately 798,144 via a 1-for-15 reverse split, effective at market open on August 31, 2026. This action is necessary to regain compliance with Nasdaq's $1.00 minimum bid price rule.